WhiteLab Genomics

France
Plumergat, Brittany, France, 75000

Company profile

WhiteLab Genomics company profile

WhiteLab Genomics develops a proprietary platform that leverages graph knowledge technology and machine learning to help companies discover and design new genomic therapies. WhiteLab Genomics enables genomic medicine scientists to obtain precise and comprehensive answers to key scientific and technological questions such as optimizing payload and vector design, assessing genotoxicity, and identifying optimal experimental protocols for in vivo and in vitro strategies. Whitelab Genomics guides its clients through the in-silico development phases, allowing them to quickly develop target vectors and payloads while saving valuable time needed to provide patients with access to new genomic therapies.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2019-01-01, Year

Headquarters

Postal code
75000
Country code
FR
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Total equity funding
$10.5M
Last funding
Seed / $10M / 2022-09-12
Last equity funding
Seed / $10M
Investors
3
Lead investors
3
Founders
3
Articles
11

Founders and investors

Founders

Cedric OdjeDavid DelbourgoJulien Cottineau

Lead investors

Debiopharm GroupOmnes CapitalY Combinator

Investors

Debiopharm GroupOmnes CapitalY Combinator